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Abstract 
Saphenous vein (SV) graft disease represents an unresolved problem in coronary artery 
bypass grafting (CABG). After CABG, a progressive remodeling of the SV wall occurs, 
possibly leading to the lumen occlusion, a process termed intima hyperplasia (IH).  The 
investigation of cellular and molecular aspects of IH progression is a primary endpoint 
toward the generation of occlusion-free vessels that may be used as ‘life-long’ grafts. 
While animal transplantation models have clarified some of the remodeling factors, the 
human SV pathology is far from being understood. This is also due to the lack of devices 
able to reproduce the altered mechanical load encountered by the SV after CABG. The 
manuscript describes the design of a novel ex vivo vein culture system (EVCS) capable to 
replicate the altered pressure pattern experienced by SV after CABG and reports the 
results of a preliminary biomechanical conditioning experimental campaign on SV 
segments. The EVCS applied a CAGB-like pressure (80-120 mmHg) or a venous-like 
perfusion (3 ml/min, 5 mmHg) conditioning to the SVs, keeping the segments viable in a 
sterile environment during 7-day-culture experiments. After CABG-like pressure 
conditioning, SVs exhibited a decay of the wall thickness, an enlargement of the luminal 
perimeter, a rearrangement of the muscle fibers, and a partial endothelium denudation. 
Considering these preliminary results, the EVCS is a suitable system to study the 
mechanical attributes of SV graft disease, and its use, combined with a well-designed 
biological protocol, may be of help in elucidating the cellular and molecular mechanisms 
involved in SV graft disease. 
 
Keywords: ex vivo vessel culture system, coronary artery by-pass grafting, saphenous 
vein remodeling, pulsatile pressure stimulation, mechanical conditioning, saphenous vein 
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graft disease 
1. INTRODUCTION 
Coronary artery bypass grafting (CABG) using autologous vessels is a widely used 
procedure to recover myocardial perfusion in patients with coronary artery disease (de 
Waard et al., 2006; Parang and Arora 2009; Wallitt et al., 2007). The saphenous vein 
(SV), due to its length and its superficial anatomical position, represents a preferred 
natural bypass conduit, especially when the implantation of multiple bypasses is required 
(Dashwood and Loesch 2009; Muto et al., 2010; Severyn et al., 2004; Surowiec et al., 
2000).  Compared with artery-made bypasses (radial and mammary arteries) SV grafts 
show lower long-term patency; in fact, approximately 15-30% of vein grafts fail during 
the first year and more than 50% patients require re-intervention within 10 years after 
implantation (Goldman et al., 2004; Tsui and Dashwood 2002). The major cause of SV 
graft failure is an over-proliferation of smooth muscle cells (SMCs) into the vessel intima 
layer. This process, named intimal hyperplasia (IH) can be detected between 1 month and 
1 year after graft implantation (Lemson et al., 2000; Motwani and Topol 1998). However, 
the beginning of the pathology occurs at much earlier stages after implantation (one 
week), with the activation of biomechanical- and inflammatory-driven cascades priming  
vessel remodeling (Mitra et al., 2006; Muto et al., 2010). The new hemodynamic 
conditions experienced by vein after implantation in arterial position are postulated to be 
an important cause for SV remodeling. In particular, in the coronary artery, the blood flow 
is characterized by a high pulsatile pressure (80 - 120 mmHg) and a pulsatile flow (mean 
flow rate of 250 ml/min), which results in an elevated shear stress (1 - 7 Pa) (Bouten et al., 
2011; Dummler et al., 2011). Such forces may have antagonistic effects on disease 
progression. Indeed elevated shear stress may have an atheroprotective role due to 
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haemodynamic-related increase of nitric oxide (NO) release by endothelial cells while a 
non-physiologic mechanical loading of the vein wall may have a pro-pathologic effect due 
to mechanical ruptures in the endothelial layer and abnormal strain of SMCs sheets (John 
2009).  
Various animal models have been devised to address the pathologic evolution of the 
arterialized veins. These studies have highlighted the relevance different cell types and 
signal transduction pathways involved in the initiation of phenomena leading to IH 
(Hoglund et al., 2010; Torsney et al., 2005). Despite these approaches, however, the 
establishment of IH in human arterialized vein is still far from being understood, thus 
posing the need for novel experimental models to be set up in order to: i) tightly reproduce 
the altered hemodynamic conditions, especially the raise in wall strain, ii) obtain ex vivo 
arterialized SV segments for investigating the mechano-biological basis of the early events 
leading to IH at global molecular level, and iii) in perspective attempt therapeutic 
strategies by pharmacological conditioning of the dynamically cultured vein segments. As 
we have discussed recently, various devices, tailored to perform ex-vivo culture of human 
SVs for a period of time spanning from 4 to 14 days and under dynamic conditions, have 
been devised (Piola et al., 2012).  
In this manuscript we propose the design of a compact and automated ex-vivo vessel 
culture system (EVCS) able to artificially produce the effects of the arterial pressure-
related cyclic wall distention, one of the major biomechanical causes of IH in venous 
CABGs together with the pulsatile wall shear stress (Anwar et al., 2012; Berceli et al., 
1990; John 2009; Muto et al., 2010; Owens 2010; Stigler et al., 2012). This aim is 
achieved by the development and functional assessment of a low-volume, reliable and 
user-friendly device, capable to replicate automatically the pulsatile pressure patterns of 
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the physiological coronary environment. In perspective, the present EVCS could be used 
as tool to carry out molecular and cellular studies in order to better understand the impact 
of modified hemodynamic conditions on in vivo SV remodeling. 
 
2. MATERIALS AND METHODS 
2.1 Design of the EVCS 
Design specification 
The design of the EVCS took into account the general specifications of a bioreactor for 
tissue engineering application (Martin et al., 2004), with particular emphasis on the ease 
of assembly under laminar flow hood, and the safety of use in a cell culture laboratory. 
Specifically, the following basic requirements were addressed: i) biocompatibility of 
materials, ii) transparency, to ensure visual inspection for air bubble and/or medium color 
changes, iii) compatibility with sterilization processes, e.g., via autoclaving and/or 
ethylene-oxide (EtO), iv) minimization of priming volume, in order to limit the cost of 
soluble culture medium compounds, and finally v) easiness of vessel accommodation and 
handling during the EVCS assembly. 
 
Architecture of the ex-vivo vessel culture system 
The EVCS is designed to apply a CABG-like pressure stimulation (CABG-PS), i.e. a 
pulsed pressure oscillating between a diastolic minimum and a systolic maximum (e.g., 
80-120 mmHg), or a steady flow perfusion, i.e., a physiological venous perfusion 
condition (VP, e.g., 5 mmHg) within a controlled and strictly reproducible mechanical 
environment. A schematic representation of the system’s layout is shown in Figure 1C. 
During culture, SV grafts are hosted in a culture chamber accommodated inside an 
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incubator. The culture chamber is connected to a hydraulic circuit and actuators (pump 
and solenoid pinch-valve) to apply pressure stimulation to the human vessels or to allow 
the medium recirculate within the vessel. The hydraulic actuators are managed by a 
programmable monitoring and control (M/C) system, which operates via a pressure-based 
feedback loop. 
 
SV culture chamber 
The culture chamber (Figure 1A) includes a commercial reservoir and a purpose-
developed vessel housing which is integrated with the reservoir cap. All the culture 
chamber parts built in house were designed with 3D-CAD Pro/Engineer Wildfire 4.0 
(PTC, Needham, MA), and manufactured by laser cutting (Versalaser VSL2.30, SK Laser, 
Germany), and/or computer numerical control machining (Modela MDX-40, Japan) from 
polymethylmethacrylate blocks (Plasting S.r.l., Segrate, Italy). All the utilized materials 
are suitable for EtO sterilization. The vessel housing allows hosting SV samples up to 5.5 
cm in length. The hosted vessel segment is cannulated at both ends using polypropylene 
(PP) barbed fittings (Cole Parmer, IL, USA), and secured using an extensible vessel loop 
(Esafarma S.r.l., Italy) as an elastic tourniquet. A standard 50-ml falcon tube (International 
PBI S.p.A, Italy) acts as a medium reservoir. The reservoir and the housing are coupled 
trough a silicone O-ring. 
Five ports through the cap ensure the chamber’s connection to the outside. Two ports 
ensure injection/removal of the culture medium to/from the vessel (Figure 1A, port a and 
b). Two other ports provide connection for recirculation of the reservoir medium, i.e. the 
medium external to the hosted SV (Figure 1A, port c and d). One additional port provides 
communication with the incubator environment through a HEPA filter, to guarantee a 
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sterile gas exchange while keeping the pressure inside the culture chamber atmospheric 
(Figure 1A, port e).  
 
The hydraulic circuit 
The hydraulic circuit consists of silicone tubing (Platinum Cured, Cole Parmer, IL, USA) 
and PP-based pump tubing (PharMed BPT®, Carlo Erba Reagenti, Milano, Italy). PP luer 
connectors (Cole Parmer, Cole Parmer, IL, USA) are used to guarantee leak-free 
connections, and facilitate circuit assembly under laminar flow hood. A 5-ml syringe, 
filled with 1.6 ml of culture medium and 3.4 ml of air, acts as a compliance chamber for 
damping pump disturbances. 
The tubing length was dimensioned in order to minimize the head loss along the hydraulic 
circuit during the vessel stimulation period. Further, the silicone tubing length was 
dimensioned according to an analytical model (Orr and Burg 2008) based on the balance 
between oxygen depletion (vessel cell metabolism) or replenishment (silicone tubing) in 
order to guarantee appropriate vessel oxygenation. Briefly, the oxygen consumption of 
native vascular tissue was set equal to 3.57 10-3 mlO2/min, assuming an oxygen demand of 
3.57 10-6 mlO2/(min kg) and considering the mass of a SV graft to be about 1 g (Hoenicka 
et al., 2010). In this condition, the necessary silicone tubing size resulted to be at least 250 
cm long. 
 
Monitoring and control system 
The M/C system is able to automatically apply the CABG-PS to the SV segments or the 
SV perfusion by automated control of a peristaltic pump (Watson Marlow 323D with 
314D pumping head, Watson Marlow Group, UK) and a solenoid pinch-valve (S305-09, 
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SIRAI® Elettromeccanica, Italy) (Figure 1C). The solenoid pinch-valve enables switching 
between the vessel stimulation loop and the recirculation loop (Figure 1D). The hydraulic 
actuators are connected to a PC equipped with a I/O board (NIDAQCard-6036E, National 
Instruments Corp.) and are managed via a customized LabView software (National 
Instruments Corp., TX, USA) adapted from Vismara and colleagues (Vismara et al., 
2009). The pressure sensor Press-S-000 (PendoTECH, NJ, USA) provides the intraluminal 
pressure feedback signal to the software (Figure 1C).  
 
2.2 Functional experiments for testing the performance of the EVCS 
SV sample preparation 
In the present investigation, the use of human SV segments was authorized by the local 
Ethical Committee with the approval of an informed consent. SV segments were obtained 
from the Department of Cardiovascular Surgery of the Centro Cardiologico Monzino. 
Briefly, surplus segments of SV were obtained from 19 patients undergoing CABG 
surgery (mean age of 66.7±7.4). SV samples were harvested with a “no touch” technique 
avoiding venous spasm and dilatation, and ensuring endothelial, medial and adventitial 
integrity (Dashwood and Tsui 2013). The distal end of each SV segment was cannulated in 
the operating room, thus allowing the identification of the valve direction, side branches 
were ligated, and SVs were immediately stored at 4°C in Dulbecco Modified Eagle’s 
Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS), 1% L-Glutamine, 
and 1% Penicillin/Streptomycin. All the SV segments were maintained at 4°C for up to 
48h before their use. Six SV samples were used for the compliance measurements, two 
samples were used for the functional validation of the EVCS, and eleven samples were 
used for the remodeling study. In all the experiments described in the following 
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paragraphs, the distal end of each sample was mounted onto the inlet connector of the 
devices after gently removing the existing cannula. 
 
Pressure-volume measurements of SV segments 
Pressure-volume relationship of human SV segments was obtained in order to dimension 
the fluid volume that the pump has to process for obtaining the desired pressure 
increments within the vessel. To this aim, a custom-made system was developed to 
measure the pressure-volume relationship during SV filling. A Schematic diagram of the 
custom-made system is reported in Figure 2A. For each SV specimen (n=6, length of the 
sample > 35 mm), the inner diameter (Di) was measured using a caliper. Then, each SV 
segment was mounted in the custom-made system and pre-tensioned by imposing a 10% 
axial strain, corresponding to a length named l10%. Table 1 reports the geometrical 
characteristics (Di and l10%) of the SV and the volume at zero pressure (V0), calculated as 
the volume of a straight cylinder of diameter equal to Di and length equal to l10%. SV 
segments were pre-conditioned by imposing five cycles of loading (0 to 120 mmHg) and 
unloading (120 to 0 mmHg), as described in the literature (Costantino et al., 2004). 
Thereafter, the vessel lumen was exposed to incremental pressure (0 to 120 mmHg, step 
10 mmHg) and the associated inner volume increment was measured (ΔV, Figure 2A) 
using an interposed graduated pipette. For each sample, this procedure was repeated three 
times. The volume increment was normalized to V0.  
 
Functional assessment of the EVCS 
Preliminary tests were performed using a SV sample, mounted within the EVCS, in order 
to verify the robustness and the reliability over time of the system. The EVCS was placed 
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in the incubator and the performances were evaluated by changing the pulse frequency and 
the pressure stimulation range. The tested pulse frequency was 0.5 Hz, 0.75 Hz, 1 Hz and 
1.2 Hz, while the pressure range was 60 – 90 mmHg (Hypotension), 80 – 120 mmHg 
(Normal) and 100 – 140 mmHg (Hypertension). 
For the following tests the EVCS components were sterilized by EtO or autoclaving, 
where appropriate. The EVCS sterility maintenance was verified with two tests using a 
sterile silicone vessel substitute and a SV sample. In both conditions, the system was 
assembled under laminar flow hood and filled with 42 ml Roosvelt Park Memorial 
Institute medium 1640 (RPMI, Lonza Group LTD, Switzerland) without antibiotics, and 
placed in the incubator (37°C and 5% CO2) for 7 days with a partial medium replacement 
at day 3, reproducing standard culture conditions. As a control, a Petri dish containing the 
same medium was also incubated. At every time step (day 0, day 3, and day 7) the culture 
medium was added to the Thioglycollate broth (BD, Maryland, USA) for microbiological 
analyses. 
 
Mechanical conditioning of human SV within the EVCS 
Generally, SV samples were divided into two segments (only for one sample, the length of 
the sample was sufficient for cutting the vein into three segments). One portion was 
immediately stored and used as control (native segment); the second portion (length > 5.5 
cm) was cultured in the EVCS. SV samples were cultured under CABG-PS conditions 
(luminal pressure: 80 - 120 mmHg; pulse frequency (f): 0.5 Hz with a stimulation interval 
(Ts) of 10 minutes; recirculation flow rate (QR): 1 ml/min, with a luminal pressure 
between 1-2 mmHg, and recirculation interval (TR) of 2 min), or VP conditions (steady 
flow with luminal pressure: 5 mmHg; flow rate: 3 ml/min). After the sterilization of the 
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EVCS, SV segments were mounted as previously described, and then the EVCS was filled 
with 42 ml DMEM with 10% Fetal Bovine Serum (FBS), 1% L-Glutamine, 1% 
streptomycin-penicillin. Then, the EVCS was kept in the incubator at 37° C and 5% CO2 
for a culture period of 7 days. The culture medium was partially changed at day 3. At the 
end of the mechanical conditioning period, SV samples were disassembled, vein ends 
were discharged (thus avoiding any edge effects induced by the mounting onto rigid 
connectors), and the central portion of the SV was processed for the following analyses. 
 
Tissue viability evaluation 
Rings of cultured and native (positive control) SV samples were stained with 
methylthiazol tetrazolium (MTT, Sigma Aldrich) (Miyakawa et al., 2008). MTT powder 
was dissolved in PBS, obtaining a final concentration of 0.5 mg/ml. SV rings were 
incubated at 37°C for 1 hour in PBS/MTT solution. As a negative control, a SV ring was 
fixed with 4% formaldehyde overnight and then incubated with MTT staining. After 1 
hour, pictures were taken using a stereo microscope (STEMI 2000-C, Carl Zeiss®, 
Germany). 
 
Morphological and immunofluorescence assessment of the mechanically conditioned 
human SV segments 
Cultured (n = 6 VP and n=6 CABG-PS treated samples) and control (n=11) SV samples 
were fixed with 4% formaldehyde overnight, paraffin embedded, and cut in 5-µm-thick 
sections using a microtome. Sections were stained with Masson’s trichrome staining  (Bio-
Optica Milano SpA, Italy), according to manufacturer’s protocol. Six slices of each SV 
sample were observed for qualitative inspection, and digital images were acquired using a 
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light microscope (AxioVision Bio Software, Carl Zeiss®, Germany) at a magnification of 
10x. 
For immunofluorescence (IF) analysis, 3 samples for each group (VP, CABG-PS and 
related controls) were observed (6 slices for each sample). Briefly, 4-µm-thick sections 
were obtained from formalin-fixed/paraffin-embedded SV specimens. Sections were 
dewaxed and hydrated, and antigen retrieval was performed with 10mM Tris-HCL/1mM 
EDTA for 10 minutes in microwave. Therefore, sections were blocked with 3% bovine 
serum albumin (room temperature, 1 hour), and incubated (4°C, overnight) with mouse 
anti human-αSMA (1:500; cat. M-0851, Dako) for labeling SMCs, goat anti human-CD31 
(1:200; cat. sc-1506 Santa Cruz Biotechnology, Inc.) and rabbit anti-human vWF (1:200; 
cat. A-0082 Dako) for labeling endothelial cells (ECs). Slides were incubated with Alexa 
Fluor 488 anti-mouse, Alexa Fluor 546 anti-goat, and Alexa Fluor 633 anti-rabbit (1:200; 
Invitrogen) secondary antibodies for 1 hour at room temperature, and nuclei were 
counterstained with DAPI (Vector Laboratories, CA, USA). Finally, digital images were 
obtained using a multicolor detection protocol in a LSM-710 confocal scanning 
microscope (Carl Zeiss®, Germany). 
 
Morphometric measurements 
Morphometric analyses were performed on Masson’s trichrome stained sections in order to 
measure thickness and luminal perimeter. One section for each sample was used. 
Thickness measurements were manually processed on digital images taken with 
AxioVision Bio Software (Carl Zeiss®, Germany) at 10X magnification. At least 40 
measurements per sample were made. The inner perimeter was calculated using Image-J 
software (Version 1.47f-sofware for Java, National Institutes of Health, USA).  
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Statistical analysis 
Statistical comparison was performed using Graph-Pad 5 (Prism) statistical software. All 
data were initially analysed with the Kolmogorov-Smirnov normality test and then 
compared using a non-parametric Mann Whitney test. A p value <0.05 was assumed as 
statistically significant in all statistical tests. 
 
3. RESULTS 
Pressure-volume measurements of SV segments 
Figure 2B reports the pressure-volume relationship obtained by progressively inflating 
fluid volume in human SV segments. The results showed an initial rapid volume rise with 
the first pressure increment step from 0 to 10 mmHg (a physiologic pressure range for 
veins), followed by a decreasing slope of the pressure-volume relationship, indicating that 
a considerable stiffening of the SV tissue progressively occurred when shifting towards 
the arterial pressure range (Figure 2B).  
Figure 2C reports the luminal volume increment within the vein after imposing a pressure 
in the range of 0 – 10 mmHg, 10 – 80 mmHg and 80 – 120 mmHg. According to these 
results, the mean inflation fluid volume necessary to generate a pressure increment from 
80 mmHg to 120 mmHg, was 0.06±0.025ml (Figure 2C). This value was used as rough 
estimate for selecting the dimensions of the relevant hydraulic components, such as the 
volume of the compliance chamber and the inner diameter of the pump tubing.  
 
Preliminary functional assessment and setting of EVCS stimulation program 
An overview of the EVCS during the assembling phase under laminar flow hood is shown 
in Figure 3 (Video_1_SuppInf.avi in the Supporting information on-line section). The time 
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necessary to fix the vein to the housing (Figure 3A, B, C and D) was less than 15 minutes; 
during this period the SV was constantly kept hydrated by pipetting culture medium on the 
SV surface. Finally, the housing was inserted within the reservoir, and connected to the 
hydraulic circuit (Figure 3E). Once assembled, the EVCS was placed in the incubator and 
the culture under mechanical conditioning started imposing either a VP condition or a 
CABG-PS.  
The CABG-PS program consists of a cyclical alternation of a pulsatile stimulation period 
and a recirculation period. Particularly, the single cycle is composed of four steps (Figure 
1B):  i) the loading step, in which the culture medium is delivered through the vessel until 
the intraluminal pressure reaches a lower pressure limit (Pmin); ii) the pulsatile stimulation 
step, during which the vessel is inflated and deflated in order to apply a controlled CABG-
PS within the pre-defined pressure ranges (Pmin - Pmax) and for a pre-defined time and 
number of pulses per minutes; iii) the unloading step, in which the intraluminal pressure 
within the vessel is lowered again to zero (P0) by inverting the medium flow direction; and 
finally, iv) the recirculation step, characterized by a constant flow rate allowing a 
metabolic supply to the vessel for a predefined recirculation period. The user can set all 
the specific parameters via the software interface, namely Pmin and Pmax, the pulse 
frequency  and the number of pulses  for the pulsatile stimulation period; the duration  and 
the medium flow rate for the recirculation period. 
Figure 4A reports representative screen printouts of the M/C software of the EVCS, 
showing an example of pressure tracing during the CABG-PS cycle. The outcomes of the 
functional tests indicated a good reliability of the M/C system. Figure 4B shows the 
system’s response to different pressure conditions reproducing hypertension (100 – 140 
mmHg), normal (80 – 120 mmHg) and hypotension (60- 90 mmHg) conditions; while the 
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system’s response to different values of frequency (0.5, 0.75, 1 and 1.2 Hz) is shown in 
figure 4C. In both configurations, the stimulation pressure tracings are fairly regular, 
repeatable and compliant to the user’s settings. Finally, microbiological tests showed no 
contamination in the culture medium after 7 days of culture in either tested configurations 
(silicone vessel or SV sample). Absence of any apparent contamination was also observed 
in the subsequent CABG-PS and VP culture tests. 
 
Validation of the EVCS during culture under mechanical conditioning. 
The culture of SV segments for 7 days under VP and CABG-PS conditions was finally 
performed in the EVCS. At the end of the mechanical conditioning period, the vessels 
were un-mounted and immediately processed for viability, histological and IF 
investigations. 
To assess tissue viability MTT staining was used (Figure 5). This showed that after 7 days 
under VP (Figure 5A) or CABG-PS (Figure 5B) conditions the vessel viability was 
maintained similarly to freshly harvested SV rings, used as a positive control (Figure 5C). 
To assess vessel integrity and structure after VP/CABG-PS periods, Masson’s trichrome 
staining of transversally cut sections was performed. Results showed a relatively good 
integrity of the vessel structure with a good preservation of SMCs and the adventitia 
layers, and without signs of tissue degeneration and swelling (Figure 6). Changes in 
cellular arrangement were instead observed in the VP (Figure 6B) vs. CABG-PS (Figure 
6C) segments. In fact, in VP-cultured vessel segments (Figure 6B), the arrangement of 
medial SMC layers appeared similar to that present in non-cultured vessels (Figure 6A); 
by contrast, the application of CABG-PS caused an almost complete SMCs 
disarrangement (Figure 6C). To better evaluate the organization and arrangement of 
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cellular components of the SV following ex vivo culture, IF analysis for SMC marker 
αSMA was performed (Figure 6, right column). Low magnification imaging of the vessels 
confirmed a difference in the medial layer of CABG-PS vs. VP vessels again suggesting a 
loss in circumferential SMCs sheets due to the modified pressure conditions (Figure 6C, 
right column). 
The observation of the vessel structure by histochemistry and IF showed that vessels 
cultured under CABG-PS conditions had relatively thinner wall and larger lumen 
compared to VP or native vessels (Figure 6 A-C). To obtain quantitative data both 
parameters were evaluated by computer-aided measuring. As shown in Figure 6D, the 
quantitative evaluation of wall thickness and luminal perimeter revealed major 
morphometric changes in CABG-PS vs. native vessels. Interestingly, veins perfused with a 
venous pressure did not undergo remodeling, confirming that application of a CABG-like 
wall strain for 7 days was sufficient to induce structural changes in the SV.  Histological 
analyses did not allow to evaluate whether the SV endothelium is affected by change in 
pressure conditions in CABG-PS stimulated vessels. To assess this, an IF analysis for 
endothelial markers vWF and CD31 was set up, followed by low and high power confocal 
imaging (Figure 7). Panels A, B and C show, respectively, low and high power views of 
the EC layer stained in the same vessels presented in Figure 6 A, B and C. While at low 
magnification the appearance of the endothelial layer appeared similar in the three 
conditions, the high power views showed the loss of ECs integrity and the partial 
detachment of the EC layer in CABG-PS vs. native and VP-stimulated veins (compare 
panels 7C with 7A and 7B).  
 
4. DISCUSSION AND CONCLUSION 
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In the present contribution, we described the design of a novel and versatile platform to 
perform dynamic stimulation of SV segments mimicking the physiological pressure 
patterns of the coronary circulation. This is indicated as one of the major insults received 
by the SV segments following their CABG implantation (Anwar et al., 2012; Berceli et 
al., 1990; John 2009; Muto et al., 2010; Owens 2010). Hence, the rationale of its inclusion 
as a controlled factor for conditioning SV segments in our culture device is to enable ex 
vivo campaigns for elucidating the role of a major biomechanical factor in SV 
arterialization. The EVCS was verified to reliably apply the desired pressure patterns to 
SV segments and to maintain vessels viability at least for 7 days in a controlled and sterile 
environment. 
 
Enhanced versatility and automation of an ECVS for ex vivo vessel conditioning 
Regarding the EVCS design, the specifications of an easy assembly and handling were 
satisfied thanks to the technical solutions adopted. First, the entire system is very compact 
through the adoption of an integrated medium reservoir, which makes the device easy to 
be used into a standard cell culture incubator, minimizing the need for dedicated culture 
instrumentation. In addition, compactness allowed abating the overall priming volume to 
42 ml, substantially lower than the 5000 ml reported by Voisard and colleagues (Voisard 
et al., 2010) and the 300 ml stated by Clerin (Clerin et al., 2002), and comparable with the 
overall priming volume of 20 ml declared by Dummler and colleagues (Dummler et al., 
2011). Finally, working in vertical conditions facilitates the air de-bubbling through the 
HEPA-port during the assembling and filling of the EVCS and during the culture 
experiments. This configuration avoids the air bubbles accumulation within the vessel 
during the mechanical conditioning culture. 
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Compared to other EVCS reported in literature (Piola et al., 2012), with particular 
reference to the systems by Dummler and colleagues (Dummler et al., 2011) and Voisard 
and colleagues (Voisard et al., 2010), our EVCS is designed to ensure the perfusion of the 
hosted SV segments, or to impose controlled physiologic CABG-PS conditions, resulting 
in a cyclic wall circumferential strain. To this purpose, the EVCS is equipped with 
dedicated control hardware and software, which, from the user’s standpoint, implies 
interaction with a programmable and user-friendly graphical interface. In this way the 
device is suitable to automatically manage the generation of the pressure pulse or the 
medium recirculation for fluid refreshing and tissue oxygenation.  
The strategy we adopted for the pressure stimulation consists of inflating and deflating the 
SV by forcing small volumes of medium into and out of the vessel through both ends. 
Thus, a recirculation phase is mandatory in order to re-establish the correct amount of 
nutrients within the luminal region of the vein. In addition, pulse generation is based on 
the commands of a robust programmable M/C system, which operates via a pressure-based 
auto-tuning feedback loop. A main feature of the M/C system is the possibility to freely 
set different stimulation parameters such as pressure range, pulse frequency, and number 
of cycles in order to modulate properly the stimulation pattern. In this manner, a versatile 
system is envisaged with the capability to perform simultaneous stimulation of SV 
segments in different conditions to perform more stringent paired biological observations 
on SVs segments or for mechanical conditioning of tissue-engineered blood vessels.  
Our EVCS suffers from some limitations. The system does not allow for the application of 
a coronary-mimicking flow through the vessel, hence the shear stress stimulus deriving 
from the arterial transposition of the vein is not replicated. Specifically, being the net flow 
approximately zero during the stimulation period, the resulting shear stress experienced by 
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the ECs in the EVCS is negligible with respect to arterial shear stress. On the one hand, 
this allowed us to selectively study the early remodeling effects caused by wall strain 
alone as a biomechanical stimulus. On the other hand this did not represent a fully 
biomimetic condition, because in real CABG pulsatile strain is always associated to 
pulsatile wall shear. The system, however, is prone to a fully biomimetic upgrade; this will 
require minimal changes to the culture chamber design (such as, changes in conduit 
diameters), whereas appropriate refinements will be needed for the hydraulic circuit layout 
and for the M/C system. In addition, the system is not suitable for replicating the 
artery/vein compliance mismatch, hampering the possibility of study its contribution on 
the early remodeling events associated with IH. 
Pressure-volume relationship of human SVs, obtained experimentally, was used in order to 
determine the volume of medium to be processed within the vessel to obtain the desired 
intraluminal pressure oscillation within CABG-PS range. In addition, the results indicated 
that the pressure-volume curves are non-linear and revealed a considerable hardening of 
the SV tissue occurring at arterial pressures. These data fully comply with data reported in 
literature (Stooker et al., 2003). It is worth to notice that, as attested in our functionality 
tests as well as in the subsequent 7-day device use experience, pulse generation stability 
was not affected at all by the strong nonlinearity of the treated samples. From a strict 
engineering viewpoint, this is an index of the system’s robustness as an automated tool for 
biomechanical SV sample stimulation. 
 
Validation of the ECVS using human SV tissues reveals profound changes in vessel 
structure due to arterial-like wall strain. 
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A major interest for vascular biologists in developing devices to perform vessel 
biomechanical conditioning, consists in the possibility to investigate the specific 
contribution of hemodynamic forces involved in vessel pathologies. In particular, 
platforms able to apply arterial-like pressure patterns to vein segments may be crucial to 
resolve the timely issue of graft patency reduction following CABG surgery, a very 
frequent side effect of arterialization in patients receiving venous grafts (Owens 2010; 
Piola et al., 2012). 
Two major biomechanical components are believed to contribute to vein arterialization; 
these are the flow-related shear stress, which is increased in CABG due to a raise in flow 
velocity, and the wall stress/tension, which is also increased due to a switch from venous 
to arterial pressures (John 2009). Flow shear stress and wall strain may have antagonistic 
functions in vein arterialization process. In fact, arterial shear stress enhances the EC 
release of vaso-relaxing molecules such as Nitric Oxide which is also known to inhibit 
neointima formation (Berard et al., 2013; Gusic et al., 2005). By contrast the wall strain is 
involved in the remodeling of the venous wall, causing the reduction of the SV thickness, 
and the mechanical rupture of the endothelial layer and the underlying SMC sheets (John 
2009; Owens 2010; Saucy et al., 2010). 
In a wider view of addressing the role of the different mechanical components involved in 
IH, the approach followed in the present report confirms an important contribution of 
arterial-like wall strain in SV structural changes. In fact, our data indicated a clear thinning 
of the SV wall and a marked enlargement of the luminal perimeter, two parameters which 
have been found significantly changed during arterial positioning of vein segments in 
patients and animal models ((Owens 2010) and reference therein). In addition, we 
observed a contribution of the CABG-PS condition to determine microscopic ruptures in 
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the endothelial layer and a striking disarray in the SMC layers in the medial tissue, two 
factors known to predispose the vessel to pathologic remodeling (Motwani and Topol 
1998) 
 
In summary, the compact and automated EVCS appears to be a well-suited system able to 
reproduce the wall strain conditions typical of the coronary circulation. The system 
maintains an optimal tissue viability, operates under sterility and performs vessel 
stimulation in a low-volume culture chamber.  For these enhanced design characteristics 
this platform is therefore a novel laboratory-oriented tool that, will be useful to carry out 
in vitro culture campaigns under strictly controlled hemodynamic conditions and dissect 
the contribution of different biomechanical factors involved in the early IH priming in vein 
CABGs. 
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Tables  
Sample Di [mm] l10%[mm] V0 [ml] 
 
SV01 3.2 59 0.47 
 
SV02 3.1 35 0.26 
 
SV03 3.8 60 0.68 
 
SV04 3.4 35 0.27 
 
SV05 3.2 35 0.28 
 
SV06 
 
3.8 60 0.68 
Mean 3.4 46.5 0.44 
 
Table 1. Geometric values of the SV samples (n=6) used for the pressure-volume 
measurements. Dì represent the inner diameter; l10% is the length of the sample hosted within 
the custom-made device, and V0  was calculated as the volume of a straight cylinder of 
diameter Di and length l10%. 	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Figures  
 
Figure 1. Design of the EVCS. (A) 3D CAD model of the SV culture chamber. The chamber 
consists of the SV housing inserted into a 50-ml falcon tube which acts as a reservoir; a and b 
are the ports for the vessel connection sites; c and d are the ports for connecting the culture 
chamber to the hydraulic circuit; e is the port for HEPA filter. (B) Schematic diagram of the 
CABG-PS program. The CABG-PS consists of: I) a loading phase up to the lower limit of a 
pre-defined pressure range, II) a pulsatile stimulation in a pre-defined pressure range, III) an 
unloading phase, and IV) a recirculation phase. (C) Layout of the EVCS: thick lines represent 
the hydraulic circuit; thin lines represent the monitoring and control (M/C) signals. In 
particular, the M/C system manages the hydraulic actuators (a pump and a solenoid pinch-
valve) via a pressure-based signal registered by the pressure sensor. (D) Simplified layout of 
the flow paths within the EVCS during the CABG-PS cycle. During pulsatile stimulation the 
medium is forced into and out of the sample through both ends.  
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Figure 2. (A) Schematic of the custom made set-up developed for the compliance 
measurements. Pressure is measured with a manometer and inner volume increments (ΔV) are 
measured using a graduated pipette.  (B) Pressure versus volume relationship for 6 human 
SVs. An initial rapid volume rise at physiological venous pressure range (0 - 10 mmHg) is 
followed by a decreasing slope at physiological arterial pressure (80 - 120 mmHg). (C) 
Representative histogram of the inflation volume necessary to generate pressure ranges (0 – 
10 mmHg, 10 – 80 mmHg, and 80 – 120 mmHg) in the vein lumen. 
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Figure 3.	   Prototype of the EVCS during the assembling phase. (A) The SV sample is 
mounted in the housing, and (B) secured via vessel loops. (C) After vessel fixing, (D) the 
HEPA filter is mounted onto its port, and then the vessel housing is inserted within the 
reservoir and connected through a silicone O-ring coupling resulting in a compact culture 
chamber. (E) The culture chamber is then connected to the hydraulic circuit and the entire 
system is filled with culture medium. 
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Figure 4. (A) Printout of the resulting pressure tracing during the four steps of CABG-PS 
cycle. (B) Pressure tracings of CABG-PS cycle of a SV segment obtained changing the 
pressure within the ranges: 60 – 90 mmHg  (Hypotension), 80 – 120 mmHg (Normal), and 
100 – 140 mmHg (Hypertension) at a pre-defined pulse frequency of 0.5 Hz. (C) Fragments 
of CAGB-PS cycle of a SV segment obtained changing the pulse frequency (0.5 Hz, 0.75 Hz, 
1 Hz and 1.2 Hz) and applying a Normal pressure range to the vessel. 
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Figure 5. Images of SV rings stained with MTT after 7-days culture in the EVCS under VP 
(A), and CABG-PS (B) conditions. Fresh tissue and formaldehyde-fixed tissue were used as 
positive (C) and negative (D) control, respectively. The images in the figure are representative 
of the behaviour observed for 3 VP and 3 CABG-PS samples and related controls. 
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Figure 6. SV tissue sections stained with Masson’s trichrome and α-SMA/DAPI after 7-days 
culture in the EVCS. The images are representative of the behaviour observed for 3 VP and 3 
CABG-PS samples and related controls. A major rearrangement of SMCs was observed in 
CABG-PS vs. VP SVs.  In each panel, from left to right, low and high power views of 
Masson’s trichrome stained section and low power views of α-SMA stained sections are 
shown in native tissue (A), VP-cultured (B), and CABG-PS (C) SV samples, respectively.	  In 
all images, L indicates the lumen, while Ad the adventitia layer. (D) Thickness and inner 
perimeter measurements were performed on SV sections stained with Masson’s trichrome 
staining. Thickness and luminal perimeter data were compared by a non-parametric Mann 
Whitney test; the p value above the bar graph indicates the significance level in these 
comparisons. The graphs without p value indication indicate absence of statistical 
significance. 
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Figure 7. Low and high power views of representative IF images in native (A), VP-cultured 
(B) and CABG-PS (C) SV samples tissue sections stained with vWF and CD31 specific 
antibodies.  In all panels, L indicates the vessel lumen and Ad the adventitia layer. Arrows in 
the panel show vWF+/CD31+ ECs lining the SV lumen. Note the lower immunostaining in the 
CABG-like (C) vs. VP (B)/native (A) vessels and evident endothelial cell rupture as indicated 
by partial detachment of the cell from the basal lamina (*). 	  
